Movement Alert|LENS Rises 3.37% in Regular Trading, Bionic Robot Mass Production Partnership and Family Robot Commercialization Expectations Boost Shares

Market Focus08-13

On August 13, LENS rose 3.37% in regular trading, trading at HK$22.02/share, with turnover of HK$79.28 million. The stock was driven higher by dual catalysts in the robotics space.

On August 12, Wulun Technology (Anhui) and Lens Intelligent Robot (Changsha) formally signed a strategic cooperation agreement. The two parties will collaborate on bionic robot bust and head-face components featuring active degrees of freedom, jointly advancing mass production of bionic humanoid head assemblies and exploring commercialization pathways. Wulun Technology will focus on achieving more natural facial expressions and more vivid interactions, while coordinating with Lens Intelligent to optimize production stability.

Additionally, Lens Technology China President Jiang Nan disclosed that the company has co-developed several family companion robots with end customers, which are expected to launch commercially within the year. These developments reinforce the company's expanding footprint in the robotics value chain beyond its core electronic components business.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment